EE140 Comparison of the Clinical and Economic Impact of Two MRNA COVID-19 Vaccines in High Risk Individuals in Japan.

MLA

Kohli, M., et al. “EE140 Comparison of the Clinical and Economic Impact of Two MRNA COVID-19 Vaccines in High Risk Individuals in Japan.” Value in Health, vol. 26, no. 12, Dec. 2023, p. S77. EBSCOhost, https://doi.org/10.1016/j.jval.2023.09.409.

APA

Kohli, M., Hagiwara, Y., Igarashi, A., Joshi, K., Lee, A., Maschio, M., Van de Velde, N., & Beck, E. (2023). EE140 Comparison of the Clinical and Economic Impact of Two MRNA COVID-19 Vaccines in High Risk Individuals in Japan. Value in Health, 26(12), S77. https://doi.org/10.1016/j.jval.2023.09.409

Chicago

Kohli, M., Y. Hagiwara, A. Igarashi, K. Joshi, A. Lee, M. Maschio, N. Van de Velde, and E. Beck. 2023. “EE140 Comparison of the Clinical and Economic Impact of Two MRNA COVID-19 Vaccines in High Risk Individuals in Japan.” Value in Health 26 (12): S77. doi:10.1016/j.jval.2023.09.409.